HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haplotype analysis of the prostacyclin synthase gene and essential hypertension.

Abstract
Previously, we discovered 3 polymorphisms in the prostacyclin synthase (PGIS) gene: 1) T-192G, in the 5-flanking region, a novel single-nucleotide polymorphism (SNP) that is not associated with essential hypertension (EH); 2) a variable number of tandem repeat (VNTR) polymorphism, 6 nucleotides upstream from the ATG start codon, that is associated with risk of cerebral infarction; and 3) C1117A, in exon 8, an SNP that does not cause an amino acid change in codon 373, and that is associated with risk of myocardial infarction (MI). The purpose of the present study was to establish haplotypes of the PGIS gene consisting of these 3 polymorphisms, and to assess the association between these haplotypes and EH. We detected 19 haplotypes. There was no significant difference in the overall distribution of haplotypes between EH and normotensive subjects. To summarize, we successfully identified haplotypes of the PGIS gene, and these haplotypes were not associated with EH.
AuthorsTomohiro Nakayama, Masayoshi Soma, Akira Haketa, Noriko Aoi, Kotoko Kosuge, Mikano Sato, Katsuo Kanmatsuse, Shinichiro Kokubun
JournalHypertension research : official journal of the Japanese Society of Hypertension (Hypertens Res) Vol. 26 Issue 7 Pg. 553-7 (Jul 2003) ISSN: 0916-9636 [Print] England
PMID12924623 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytochrome P-450 Enzyme System
  • Intramolecular Oxidoreductases
  • prostacyclin synthetase
Topics
  • Adult
  • Aged
  • Case-Control Studies
  • Cytochrome P-450 Enzyme System (genetics)
  • Female
  • Haplotypes
  • Humans
  • Hypertension (genetics)
  • Intramolecular Oxidoreductases (genetics)
  • Japan
  • Male
  • Middle Aged
  • Minisatellite Repeats
  • Polymorphism, Single Nucleotide
  • Polymorphism, Single-Stranded Conformational

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: